Skip to main content
. 2022 Feb;23(2):641–650. doi: 10.31557/APJCP.2022.23.2.641

Table 2.

Frequency of EBV Infection in Breast Cancer Patients and Controls

Control group
No. (%)
BC patients
No. (%)
P-value OR (95% CI)
Anti- VCA IgG (n) 220 142
Seronegative 40 (18.2) 22 (15.5) Reference
Seropositive 180 (81.8) 120 (84.5) 0.507 1.2 (0.68-2.14)
EBNA-1 gene (n) 180 120
Negative 142 (78.9) 66 (55) Reference
Positive 38 (21.1) 54 (45) <0.001 3.05 (1.84-5.07)

EBV, Epstein-Barr virus; VCA, Viral capsid antigen; EBNA, Epstein Barr virus nuclear antigen; BC, breast cancer.